Global Duodenal Stent Market Size By Type (Polymer Duodenal Stent, Metal Duodenal Stent), By Application (Hospitals, Ambulatory Surgical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Duodenal Stent Market was valued at USD 170.2 million in 2023 and is projected to surpass USD 268.5 million by 2031, growing at a CAGR of 5.8% during the forecast period of 2023–2031. The increasing prevalence of gastrointestinal obstructions, particularly due to malignancies such as pancreatic and duodenal cancers, is a primary driver of the market. Duodenal stents are essential in palliative treatment by relieving obstructions and improving patients' quality of life. Moreover, advancements in stent design and minimally invasive endoscopic techniques are further accelerating market growth.

Drivers:

1. Rising Incidence of Gastrointestinal Cancers:

An upsurge in GI malignancies is resulting in a greater number of patients requiring palliative care, where duodenal stents offer a non-surgical solution to obstruction management.

2. Technological Advancements in Stent Design:

The development of drug-eluting and biodegradable stents is significantly enhancing treatment outcomes, reducing complications like migration and restenosis.

3. Growing Preference for Minimally Invasive Procedures:

Healthcare providers and patients are increasingly opting for endoscopic stenting over surgical alternatives due to reduced hospital stays, lower costs, and quicker recovery times.

Restraints:

1. Complication Risks and Device Failures:

Stent migration, perforation, and re-obstruction remain significant clinical concerns, which may limit widespread adoption.

2. Limited Access in Low-Income Regions:

High procedural costs and limited healthcare infrastructure in developing countries restrict market penetration.

Opportunity:

1. Expansion in Emerging Healthcare Markets:

Rapid improvement in healthcare infrastructure across Asia-Pacific and Latin America offers untapped potential for duodenal stent manufacturers.

2. Integration with Imaging & AI:

The fusion of endoscopic stent placement with real-time imaging and AI-guided navigation systems holds promise for enhanced procedural accuracy and better patient outcomes.

Market by System Type Insights:

By system type, self-expanding metal stents (SEMS) dominated the market in 2023 due to their superior patency rates, flexibility, and ease of deployment. Covered SEMS are particularly gaining traction owing to their effectiveness in preventing tumor ingrowth. Meanwhile, plastic stents remain in use for short-term applications but are gradually being replaced due to higher complication rates and frequent replacements.

Market by End-use Insights:

Hospitals constituted the largest end-use segment in 2023, driven by the availability of advanced endoscopic infrastructure and a multidisciplinary approach to gastrointestinal obstruction treatment. Specialty clinics are anticipated to witness the fastest growth due to the increasing trend toward outpatient endoscopy services and cost-effective palliative care setups.

Market by Regional Insights:

North America led the global market in 2023, supported by a high prevalence of GI cancers, widespread adoption of minimally invasive procedures, and strong reimbursement frameworks. However, Asia-Pacific is projected to experience the highest CAGR during the forecast period due to an expanding patient base, improved healthcare access, and increasing awareness of endoscopic solutions.

Competitive Scenario:

Key players in the Global Duodenal Stent Market include Boston Scientific Corporation, Cook Medical, Taewoong Medical Co. Ltd., Olympus Corporation, Becton, Dickinson and Company (BD), CONMED Corporation, and Micro-Tech (Nanjing) Co., Ltd. These companies are actively investing in product innovation, regulatory approvals, and regional expansion.

Recent Developments:

In 2024, Boston Scientific received FDA clearance for its next-generation covered SEMS with enhanced anti-migration features.

Cook Medical expanded its endoscopy portfolio in 2023 with a new range of customizable duodenal stents tailored to anatomical variability.

In 2025, Olympus launched an AI-integrated stenting navigation system to assist in precision-guided endoscopic stent placement.

Scope of Work – Global Duodenal Stent Market

Report Metric Details

Market Size (2023) USD 170.2 million

Projected Market Size (2031) USD 268.5 million

CAGR (2023–2031) 5.8%

Market Segments By System Type (SEMS, Plastic), By End-use (Hospitals, Specialty Clinics), By Region

Growth Drivers Rising GI cancer incidence, Technological advancements, Minimally invasive preference

Opportunities Expansion in emerging markets, AI-integrated stenting

Key Market Developments:

2024: Boston Scientific launched a new line of anti-migration duodenal stents.

2023: Cook Medical released personalized stent solutions for complex anatomies.

2025: Olympus debuted a stent placement guidance system powered by AI for enhanced clinical accuracy.

FAQs:

1) What is the current market size of the Global Duodenal Stent Market?

The Global Duodenal Stent Market was valued at USD 170.2 million in 2023.

2) What is the major growth driver of the Global Duodenal Stent Market?

The major growth driver is the increasing prevalence of gastrointestinal cancers and the preference for minimally invasive treatment options.

3) Which is the largest region during the forecast period in the Global Duodenal Stent Market?

North America holds the largest market share, but Asia-Pacific is expected to grow at the fastest pace.

4) Which segment accounted for the largest market share in the Global Duodenal Stent Market?

Self-expanding metal stents (SEMS) accounted for the largest share by system type.

5) Who are the key market players in the Global Duodenal Stent Market?

Boston Scientific, Cook Medical, Olympus Corporation, Taewoong Medical, and BD are among the leading market players.